ASMB
Assembly Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.60
+1.30%Aug 13, 2026, 22:16 UTC
Assembly Biosciences reported a Q2 2026 loss of $0.20 per share, beating the Zacks Consensus Estimate of a $0.70 loss and improving from a $1.33 loss a year earlier.
Source:Jun 5, 2026, 00:00 UTC
Assembly Biosciences, Inc. elected Anthony E. Altig, Tomas Cihlar, Gina Consylman, Robert D. Cook II, and Sir Michael Houghton as directors effective June 4, 2026.